Pharmacological characterization of the small molecule 03A10 as an inhibitor of α-synuclein aggregation for Parkinson’s disease treatment
Qing Wang(Shaoxing People's Hospital), Linyin Feng(Chinese Academy of Sciences)
Cited by 21
Related Papers
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
|Brain|2021|262
The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
|Brain|2020|167
Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
|Frontiers in Immunology|2021|110
Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity <i>via</i> AMPK/SOD2 Pathway
|Aging and Disease|2023|71
Inhibition of Histone Deacetylase 3 (HDAC3) Mediates Ischemic Preconditioning and Protects Cortical Neurons against Ischemia in Rats
|Frontiers in Molecular Neuroscience|2016|60